Target Audience
This activity was developed for headache specialists, neurologists, primary care physicians, pain specialists, OB/GYNs, nurses, nurse practitioners, physician assistants, pharmacists, medical students, residents, and other clinicians who care for patients with primary headache disorders.
Learning Objectives
At the conclusion of this activity, participants should be better able to:
- Apply guideline-based diagnostic and evaluation strategies to diagnose and differentiate migraine from cluster headache and other primary and secondary headache disorders
- Evaluate acute and preventative pharmacological therapies to develop an individualized treatment plan
- Foster stronger patient adherence through shared decision
- Utilize the shared decision-making process with patients who have a primary headache disorder to individualize treatment
Faculty
Jessica Ailani, MD, FAHS Director
MedStar Georgetown Headache Center
Associate Professor of Neurology Medstar Georgetown University Hospital
Washington, DC
Gregory Scott, PharmD WriteHealth, LLC
Kennebunk, Maine
Stewart J. Tepper, MD Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire
Director, Dartmouth Headache Center
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Accreditation
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical education for
physicians.
The Annenberg Center for Health Sciences at Eisenhower designates
this enduring activity for a maximum of
1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
Annenberg Center for Health Sciences at Eisenhower is accredited
as a provider of nursing continuing professional development by the American Nurses
Credentialing Center’s Commission on Accreditation.
A maximum of
1.5 contact hours
may be earned for successful completion of this activity.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance,
independence, objectivity, and scientific rigor in all programming. All individuals with the
potential to impact the content of an accredited education activity are expected to identify and
reference off-label product use and disclose relationships with ACCME-defined ineligible
companies.
The Annenberg Center for Health Sciences assesses relevant relationships with its instructors,
planners, managers, and other individuals who are in a position to control the content of CE
activities. All relevant relationships that are identified are thoroughly vetted by the
Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity,
and patient care recommendations. The Annenberg Center is committed to providing its learners
with high-quality CE activities and related materials that promote improvements or quality
in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel
documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the
following disclosures have been made:
Disclosures
Jessica Ailani, MD, FAHS Advisory Board
- AbbVie, Axsomem, Biohaven, Impel, Lilly, Satsuma,Teva
Consultant
- AbbVie, Biohaven, Lilly, Lundbeck, Satsuma
Research Support
- AbbVie, Biohaven, Lilly, Zosano
Speakers Bureau
- AbbVie, Biohaven, Lilly, Lundbeck, Teva
Gregory Scott, PharmD No significant relationship to disclose
Stewart J. Tepper, MD Research Support
- Allergan, Amgen, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Lundbeck, Neurolief, Novartis, Satsuma, Scion Neurostim, Teva, Zosano
Consultant and/or Advisory Board
- Acorda, Aeon, Alexza, Align Strategies, Allergan, Alphasights, Amgen, Aperture Venture Partners, Aralez Pharmaceuticals Canada, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, Charleston Labs, CRG, Currax, Decision Resources, DeepBench, Eli Lilly, eNeura, Equinox, ExpertConnect, GLG, GSK, Guidepoint Global, Healthcare Consultancy Group, Health Science Communications, Impel, Lundbeck, M3 Global Research, Magellan Rx Management, Marcia Berenson Connected Research and Consulting, Medicxi, Navigant Consulting, Neurolief, Nordic BioTech, Novartis, Pulmatrix, Reckner Healthcare, Relevale, Revance, SAI MedPartners, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Spherix Global Insights, Sudler and Hennessey, Synapse Medical Communications, Teva, Theranica, Thought Leader Select, Trinity Partners, XOC, Zosano
Stock options
The faculty for this enduring activity has disclosed that there will be
discussion about the use of products for non-FDA approved applications.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationships to disclose.
Heather M. Jimenez, FNP-C (Nurse Planner)No significant relationships to disclose.
Gregory Scott, PharmD, RPh (Medical Writer)No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial
relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
The ideas and opinions presented in this educational activity are those of the faculty and do not
necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational
activities, we encourage practitioners to use their own judgment in treating and addressing the
needs of each individual patient, taking into account that patient's unique clinical situation.
The Annenberg Center disclaims all liability and cannot be held responsible for any problems
that may arise from participating in this activity or following treatment recommendations
presented.
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the material,
reflecting on its implications in your practice, and completing the assessment
component.
The estimated time to complete the activity is
01:30 hour.
This activity was originally released on
2020-12-14 and is eligible for credit through
2021-12-14.
Our Policy on Privacy
Annenberg Center for Health Sciences respects your privacy. We don’t share information you
give us, or have the need to share this information in the normal course of providing the
services and information you may request. If there should be a need or request to share this
information, we will do so only with your explicit permission. See Privacy Statement and other
information at https://annenberg.net/pages/privacyPolicy.php
Contact Information
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
ce@annenberg.net
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM,
Pacific Time, Monday – Friday